40+ years building & scaling health & sports businesses, including a Quebec paramedical & sports medicine center. 15+ Taekwondo schools Quebec, France, California. Created and hosted Quebec national TV fitness shows and training DVDs distributed across Canada. Since 2010, focused on medical-device R&D, leading financing, development plans, and clinical studies across KAT entities and partners. Proven operator with global execution experience.

Prof/Director of the Depart of Physical Activity at UQAM. Active researcher with Canadian Space Agency, informing musculoskeletal & cardiorespiratory physiology in microgravity. Contributes to stimulation parameter selection, study design, data interpretation, bridging academic research, clinical application, & future space-countermeasure opportunities. Maintains strong research & industry partnerships that support validation & credibility.

Professor of Orthopedic Surgery in Tunis, head of an orthopaedic department since 2013. General orthopedic surgeon focused on hip, knee arthroplasty, adult spine surgery. Board member and founding board member of the Tunisian Society of Orthopaedic Surgery and Research. Provides site leadership, surgical insight, & investigator network for OSTAAT™ trials in Tunisia, strengthening hospital operations & ethics compliance.

Rheumatologist and Clinical Professor at UCLA and Cedars-Sinai. Medical Director at the Osteoporosis Medical Center and its Clinical Research Center. Osteoporosis and metabolic bone disease specialist. Led NIH, state, and industry trials; 200+ peer-reviewed papers; advisory boards. Brings endpoints and trial-ops expertise plus KOLs' credibility to OSTAAT accelerating IRB readiness, site activation, and recruitment worldwide, with tight oversight.

Retired applied physiologist & co-inventor of OSTAAT. Spent 35 years at the Navy Naval Health Research Center, then founded & led a performance laboratory. Expertise includes body composition, thermal stress, vibration/shock and bone & musculoskeletal adaptation measured via biomarkers, DXA and loading models. Brings measurement discipline and translational physiology to clinical device studies, strengthening protocols and outcome interpretation.

Biomedical-electrical engineer coordinating day-to-day R&D across biomedical and electrical teams. Leads literature synthesis, experimental planning, and support for in vitro and ex vivo work. Builds project plans, manages timelines and resources, and maintains clear documentation for decisions, progress, and results. Strengthens integration between device engineering, biology, and study deliverables for OSTAAT, improving speeds and traceability.

Biomedical engineer validating OSTAAT stimulation in hip tissues. Conducts literature reviews, supports LTspice modeling, and verifies results through bench testing. Supported ex vivo pig-hip studies (setup, data capture, analysis, reporting). Will support upcoming in vivo work to refine stimulation parameters and enable safe translation into 2026 clinical programs and protocols. Brings disciplined documentation experimental rigor, and reporting.

Biomedical engineer driving verification of hip-tissue stimulation for OSTAAT. Translates literature into testable hypotheses, builds LTspice models, and designs bench protocols. Supported ex vivo pig-hip experiments (setup, recording, analysis, reporting). Will support upcoming in vivo work to refine parameters and produce traceable, regulatory-ready evidence packages with strong analytical reporting. Focuses on V&V rigor and documentation.

Clinical operations leader with 30+ years in pharma & clinical research, including 11 at Eli Lilly Canada. CEO North America at Keyrus Life Science; co-founded MedQualis and led its merger with Keyrus/Alsinova. Expert in site/CRO management, budgets, timelines, and quality oversight aligned with regulatory expectations. Drives feasibility and scalable operations for OSTAAT in North America, delivering trials on time and to standard under GCP too.

Quality & regulatory leader with 25+ years in project leadership and process optimization, plus 15 years in hardware and MedTech roles. Led multiple ISO 9001 and ISO 13485 certifications. Builds QMS, drives design controls and risk management, and strengthens supplier quality and compliance. Delivers audit-ready documentation and scalable processes supporting safe development and manufacturing scale-up for OSTAAT, through audits, CAPAs, and DHF.

Three-time health entrepreneur and marketing strategist. Founded SIXDEGRÉS (acquired by Edelman) and the Probiotic Education Alliance (acquired). Entrepreneur-in-Residence at CENTECH; mentored 100+ Tech & MedTech startups. Brings positioning, partnerships & fundraising experience to craft GTM pathways and investor narratives grounded in stakeholder value and practical execution. Strong North American network for intros and deal flows with impact.

Strategic business leader with 20+ years supporting startups and organizations on go-to-market and growth. Chief Experience Officer at mHUB Chicago; helped build 1871, MATTER, and mHUB. Board advisor to KAT via mHUB’s investment, bringing ecosystem expertise, partnership access, and practical guidance on scaling operations, customer discovery, and growth strategy. Strong Midwest network and venture ties for partnerships and follow-on fundraising.

Orthopaedic surgeon & Full Professor at Université de Montréal; Endowed Chair in Osteoarthritis & Chief of Staff (Orthopedic Surgery) at CHUM. Hip/knee reconstruction expert; Past President, SICOT World Congress 2018. Leads a Gene Therapy & Nanotech lab; raised $15M+ CAD. Authored 114+ papers, bringing academic rigor & hospital execution to OSTAAT. Experienced PI with broad networks. Guides protocol design, endpoints, and execution across Canada.